Analyzing Adherence to the 2016 Infectious Diseases Society of America Guidelines for Candidemia in Cancer Patients.
Dena M LehmannNina CohenI-Hsin LinShane AlexanderRitu KathuriaMarina KerpelevYing TaurSusan K SeoPublished in: Open forum infectious diseases (2022)
The addition of MALDI-TOF did not shorten time to effective antifungal therapy. Nearly all patients were seen by ID for candidemia. Poor cancer prognosis was a common factor for incomplete composite adherence to the 2016 IDSA candidiasis guidelines.
Keyphrases
- infectious diseases
- mass spectrometry
- end stage renal disease
- candida albicans
- ejection fraction
- newly diagnosed
- clinical practice
- papillary thyroid
- ms ms
- prognostic factors
- stem cells
- adipose tissue
- glycemic control
- young adults
- insulin resistance
- metabolic syndrome
- skeletal muscle
- mesenchymal stem cells
- bone marrow
- weight loss